Journal Detail Information

1

Cite

Share

The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma.

Jeong HEO

The Korean Journal of Hepatology.2007;13(4):576-580. doi:10.3350/kjhep.2007.13.4.576

No abstract available.

2

Cite

Share

Combined Hepatocellular-cholangiocarcinoma.

Yoon Mi JEEN ; So Young JIN

The Korean Journal of Hepatology.2007;13(4):571-575. doi:10.3350/kjhep.2007.13.4.571

No abstract available.
Bile Duct Neoplasms/*diagnosis/pathology ; *Bile Ducts, Intrahepatic ; Carcinoma, Hepatocellular/*diagnosis/pathology ; Cholangiocarcinoma/*diagnosis/pathology ; Humans ; Liver Neoplasms/*diagnosis/pathology ; Male ; Middle Aged ; Mixed Tumor, Malignant/*diagnosis/pathology

3

Cite

Share

Primary Adenosquamous Carcinoma of the Liver: A Case Report.

Mi Jin GU ; Joon Hyuk CHOI ; Won Kyu PARK ; Jay Chun CHANG ; Hong Jin KIM

The Korean Journal of Hepatology.2005;11(1):86-89.

Primary adenosquamous cell carcinoma of the liver, a variant of cholangiocarcinoma is very rare disease and its prognosis is known to be very poor. We describe here a case of primary adenosquamous carcinoma of the liver. The patient was a 60-year-old woman who complained of an eight-month history of intermittent upper abdominal pain. Abdominal computed tomography scan revealed a low density mass and intrahepatic duct stones within the dilated left intrahepatic duct in the left lateral segment. Needle biopsy of the mass was done and the histologic diagnosis was cholangiocarcinoma. Left lobectomy was then performed. Upon gross examination, there was a well defined solid mass and intrahepatic duct stone in the dilated bile duct. Microscopically, the tumor was composed of both adenocarcinoma and squamous cell carcinoma.
Carcinoma, Adenosquamous/*diagnosis/pathology ; English Abstract ; Female ; Humans ; Liver Neoplasms/*diagnosis/pathology ; Middle Aged

4

Cite

Share

A Case of Vanishing Bile Duct Syndrome Associated with Hypersensitivity to Allopurinol.

Seong Ho CHOI ; Soo Hyun YANG ; Young Bong SONG ; Hye Jin KIM ; Yeoung Tae SEO ; Dong Seog CHOI ; Kyoung Hyoub MOON ; Jong Hoon BYUN ; Eun Sil YU

The Korean Journal of Hepatology.2005;11(1):80-85.

Allopurinol is frequently used for the treatment of hyperuricemia and gout. Sometimes, a life-threatening reaction develops, as is illustrated by the following case report. We describe a 60-year-old male patient who was treated with allopurinol because of asymptomatic hyperuricemia, and he was presented with fever, skin rash, eosinophilia, worsening renal function and vanishing bile duct syndrome. In this report, we discussed vanishing bile duct syndrome as a serious side effect of allopurinol, and we briefly reviewed the etiology, prevention, and treatment modalities for vanishing bile duct syndrome.
Allopurinol/*adverse effects ; Bile Duct Diseases/*etiology/pathology ; Drug Hypersensitivity/*complications ; English Abstract ; Gout Suppressants/*adverse effects ; Humans ; Male ; Middle Aged

5

Cite

Share

Prostaglandin A2 Induces Caspase-independent Apoptosis in Hepatocellular Carcinoma Cells.

Ho Shik KIM ; Jae Chun SHIM ; Ju Youn CHOI ; Hyangshuk RHIM ; In Kyung KIM

The Korean Journal of Hepatology.2005;11(1):72-79.

BACKGROUND/AIMS: Prostaglandin (PG) A2 has been reported to inhibit the growth of hepatocellular carcinoma cells via activation of apoptosis, although the molecular mechanisms involved have not been clarified, yet. To investigate the mechanism of the PGA2-induced apoptosis, we analyzed the activation of caspases during the apoptosis of hepatoma cell lines. METHODS: Induction of apoptosis by PGA2 in hepatoma cell lines, Hep 3B and Hep G2, was assessed by DAPI staining of nuclei and agarose gel electrophoresis of genomic DNA. The involvement of caspases was analyzed by immunoblot analysis of poly ADP-ribose polymerase (PARP) and by checking the effect of caspase inhibitors on PGA2-induced apoptosis. RESULTS: PGA2 inhibited the growth of Hep 3B and Hep G2 cells, accompanying nuclear condensation and fragmentation, and genomic DNA laddering, which are the hallmarks of apoptosis. The PARP was not cleaved during the apoptosis of Hep 3B and Hep G2 cells and caspase inhibitors such as z-VAD-Fmk and z-DEVD-Fmk exerted no effect on the PGA2-induced apoptosis. CONCLUSIONS: These results suggest that PGA2 induces apoptosis in Hep 3B and Hep G2 cells via caspase-independent pathway.
Apoptosis/*drug effects ; Carcinoma, Hepatocellular/*pathology ; Caspases/antagonists & inhibitors/*metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Enzyme Activation ; Humans ; Liver Neoplasms/*pathology ; Prostaglandins A/*pharmacology ; Research Support, Non-U.S. Gov't ; Tumor Cells, Cultured

6

Cite

Share

The Comparative Results of Radiofrequency Ablation versus Surgical Resection for the Treatment of Hepatocellular Carcinoma.

Chang Min CHO ; Won Young TAK ; Young Oh KWEON ; Sung Kook KIM ; Yong Hwan CHOI ; Yoon Jin HWANG ; Yang Il KIM

The Korean Journal of Hepatology.2005;11(1):59-71.

BACKGROUND/AIMS: Although surgical resection remains the gold standard of therapy for hepatocellular carcinoma (HCC), only selected patients can undergo resection because of the severity of the underlying cirrhosis or due to the diffuse distribution of the tumor. Radiofrequency ablation (RFA) has recently shown comparable results to surgical resection for the treatment of HCC. We compared the results of RF ablation and surgical resection for the treatment of HCC. METHODS: From January 2000 to December 2002, one hundred-sixty patients who had undergone surgical resection or RFA were analyzed retrospectively. The patients with a tumor size less than 5 cm in diameter, with less than 3 tumors in number, with tumor having a Child-Pugh class A classification and no evidence of extrahepatic metastasis were enrolled in the study. The recurrence pattern was classified into local and distant recurrence. We compared the recurrence patterns, the survival rates, the recurrence rates and the complications between the two groups. RESULTS: 1) The local recurrence rate was 9.8% for surgical resection and 18.2% for RFA and the distant recurrence rate were 32.8% and 28.3%, respectively. 2) The 1-, 2- and 3-year overall cumulative survival rates after RFA and surgery were 95.8%, 86.8%, 80.0%, 98.3%, 87.0% and 77.4%, respectively. 3) The incidence of complication was similar between the two groups. CONCLUSIONS: Radiofrequency ablation shows comparable results to surgical resection for the treatment of HCC. Therefore, RFA should be considered as the treatment of choice those patients who are not candidates for resection. However, intrahepatic recurrence of tumor after RFA was as frequent as that seen after surgical resection. Further investigation is warranted to clarify whether the current RFA technology could offer improved long-term results.
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/mortality/secondary/*surgery ; *Catheter Ablation ; Comparative Study ; English Abstract ; Female ; *Hepatectomy ; Humans ; Liver Neoplasms/mortality/pathology/*surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Survival Rate

7

Cite

Share

Relationship between the Severity of Liver Damage and the Serum Leptin Level for Nonalcoholic Fatty Liver Disease.

Kyoung Oh KIM ; Sang Hoon PARK ; Cheol Hee PARK ; Tai Ho HAN ; Kyo Sang YOO ; Jong Hyeok KIM ; Myung Seok LEE ; Dong Jun KIM ; Choong Kee PARK ; Hyun Deuk CHO

The Korean Journal of Hepatology.2005;11(1):51-58.

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) represents a spectrum of conditions that are mainly characterized histologically by macrovesicular hepatic steatosis. There are two histologic patterns of NAFLD: simple steatosis alone and steatohepatitis. The factors leading from simple steatosis to nonalcoholic steatohepatitis (NASH) are still obscure. The datas from several studies have suggested that leptin could be involved in the progression from hepatic steatosis to steatohepatitis including the fibrosis. We evaluated serum leptin levels in patients with NAFLD to determine whether any relationships existed between the leptin levels and the severity of hepatic inflammation or fibrosis. METHODS: We studied 62 patients with NAFLD who were diagnosed at the Hallym University Sacred Heart Hospital from July 2001 to May 2004. We measured the serum leptin level in all cases and liver biopsy samples were obtained from 31 cases. The liver biopsy specimens were graded according to methods described by Brunt. Spearman rank correlations were used to detect the associations between the serum leptin and the various anthropometric and biochemical variables. The relationship between the histologic severity and the serum leptin level was evaluated with logistic regression analysis. RESULTS: Serum leptin levels correlated with insulin, c-peptide, ALT and homeostasis model assessment insulin resistance, but not with BMI, age and gender. Serum leptin level also correlated with hepatic fibrosis, but not with hepatic steatosis or inflammation. However, the serum leptin level was not a significant independent predictor of the grade of hepatic steatosis, inflammation and fibrosis on the univariate analysis. CONCLUSIONS: The serum leptin level was not an independent predictor of the severity of liver damage in NAFLD.
Adolescent ; Adult ; English Abstract ; Fatty Liver/blood/*pathology ; Female ; Humans ; Leptin/*blood ; Liver/*pathology ; Male ; Middle Aged

8

Cite

Share

The Prevalence and Clinical Characteristics of Hepatitis-delta Infection in Korea.

Sook Hyang JEONG ; Jung Min KIM ; Heui June AHN ; Myung Joon PARK ; Kwang Hyun PAIK ; Won CHOI ; Jin KIM ; Chul Joo HAN ; Yoo Cheoul KIM ; Jhin Oh LEE ; Young Joon HONG ; Hyo Young PARK ; Ha Hyun JEONG ; Mi Yong YOON ; Myungjin LEE ; Kee Ho LEE

The Korean Journal of Hepatology.2005;11(1):43-50.

BACKGROUND/AIMS: The prevalence of hepatitis delta virus (HDV) infection has been estimated as being approximately 5% among global HBsAg carriers. The anti-delta positive rate in Koreans had been reported as being 0.85% in 1985. While the prevalence of HBV has been decreased from nearly 10% to 5% during the past twenty years, there have been no more studies on the anti-delta prevalence in Koreans. The aim of this study was to estimate the anti-delta prevalence in Koreans and to study the clinical characteristics of anti-delta positive patients in a single center. METHODS: Serum anti-delta was measured in one hundred ninety four HBsAg-positive patients who were admitted to our hospital from February 2003 to August 2003. We checked the genotypes of the HBV in the anti-delta positive patients. The clinical features of the anti-delta positive patients were compared to those clinical features of the anti-delta negative patients from the aspect of age, gender, mode of transmission, the positivity of HBeAg and serum HBV DNA. RESULTS: Serum anti-delta was positive in seven patients among the 194 subjects, giving a 3.6% positive rate. Among these seven patients, six had hepatocellular carcinoma (HCC) and the other one had cholangiocarcinoma. All of the anti-delta positive patients had the C genotype of HBV. The anti-delta positive patients showed significantly suppressed HBV DNA replication compared to the anti-delta negative patients. CONCLUSIONS: In Koreans, anti-delta was positive mainly in HCC patients with an approximate prevalence of 4%, and this rate has not changed much for the past twenty years. HBV DNA replication was suppressed by HDV infection.
Adult ; Carcinoma, Hepatocellular/virology ; English Abstract ; Female ; Hepatitis Antibodies/analysis ; Hepatitis D/complications/*epidemiology/immunology ; Hepatitis Delta Virus/immunology ; Hepatitis delta Antigens/analysis ; Humans ; Korea/epidemiology ; Liver Neoplasms/virology ; Male ; Middle Aged ; Prevalence

9

Cite

Share

HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy.

Chun Kyon LEE ; Kwang Hyub HAN ; Jeong Hun SUH ; Young Suk CHO ; Sun Young WON ; Chae Yoon CHON ; Young Myoung MOON ; In Suh PARK

The Korean Journal of Hepatology.2005;11(1):34-42.

BACKGROUND/AIMS: Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We thought that the host immune response is important to prevent viral relapse. We compared the frequency of HBV-specific CD8+ T cells in the peripheral blood and their expansion capacity after exposure to viral antigen between the patients showing sustained HBeAg seroconversion after use of lamivudine and those patients without sustained response. METHODS: We analyzed HBV-specific CD8+ T cells that were isolated from the blood of 14 patients with HLA-A2 who showed lamivudine induced HBeAg seroconversion (HBV DNA < 0.5 pg/mL, and the cells were negative for HBeAg) at the end of lamivudine therapy. The purified T cells were directly stained ex vivo, after they had been stimulate with synthetic peptide, using the HBV core 18-27-specific HLA tetramer (Tc 18-27) and monoclonal antibody to CD8. The HBV viral load was quantified by the Amplicor HBV Monitor assay. RESULTS: In patients with a sustained HBeAg response (the sustained group) for a duration of 15.5 months of follow-up, the median number of Tc 18-27 cells out of the 5 X 10(4) CD8+ T cells was 49.5 (15-135). On the contrary, in patients who experienced relapse (the relapsed group) during a median of 7.5 months of follow-up, the median number of Tc 18-27 cells out of the 5 X 10(4) CD8+ T cells was 13.5 (0-95). Especially, among patients with a viral load of HBV DNA < 1 X 10(3) copies at the end of treatment, the median number of Tc 18-27 cells out of 5 X 10(4) CD8+ T cells was 87 (45-135) in sustained group compared to 12 (6-50) in the relapsed group. All patients in the sustained group demonstrated a vigorous expansion of the core 18-27-specific CD8+ T cells after stimulation with viral peptide, in contrast to only 3 out of 8 patients in the relapsed group. CONCLUSIONS: This study demonstrates that the frequency and functional responsiveness of the circulating HBV-specific CD8+ T cells may be important for obtaining a sustained HBeAg response to lamivudine.
Adult ; Antiviral Agents/*therapeutic use ; CD8-Positive T-Lymphocytes/*immunology ; English Abstract ; Female ; Hepatitis B/drug therapy/*immunology/virology ; Hepatitis B e Antigens/*blood ; Hepatitis B virus/*immunology ; Humans ; Lamivudine/*therapeutic use ; Male ; Recurrence ; Viral Load

10

Cite

Share

The Efficacy of Alpha-Interferon in Korean Patiens with Chronic Hepatitis B.

Kwang Cheol KOH

The Korean Journal of Hepatology.2005;11(1):31-33.

No abstract available.
Antiviral Agents/*therapeutic use ; Hepatitis B, Chronic/*drug therapy ; Humans ; Interferon-alpha/*therapeutic use ; Korea

DISPLAY OPTIONS

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share

Cite

Share